Identification of miR-200a as a novel suppressor of connexin 43 in breast cancer cells

Bioscience Reports

Volumn 35, Issue 5, 2015, Pages

  Ming, Jia ^a   Zhou, Yan ^b   Du, Junze ^b   Fan, Shenghao ^a   Pan, Beibei ^a   Wang, Yinhuan ^a   Fan, Lingjun ^b   Jiang, Jun ^b  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

3' untranslated region (3' UTR).; Breast cancer; Connexin 43 (Cx43); Metastasis; Micro ribonucleic acid (miR) 1; Micro ribonucleic acid (miR) 200a

Indexed keywords

CONNEXIN 43; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 186; MICRORNA 200A; MICRORNA 206; MICRORNA 23A; MICRORNA 23B; MICRORNA 381; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN200 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CANCER TISSUE; CELL MIGRATION; CLINICAL ARTICLE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; PROTEIN EXPRESSION; 3' UNTRANSLATED REGION; BREAST; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CONNEXIN 43; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM METASTASIS;

EID: 84943534053     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1042/BSR20150153     Document Type: Article

References (28)

1. Coughlin, S.S. and Ekwueme, D.U. (2009) Breast cancer as a global health concern. Cancer Epidemiol. 33, 315-318 CrossRef PubMed
2. Jemal, A., Center, M.M., DeSantis, C. and Ward, E.M. (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 19, 1893-1907 CrossRef PubMed
3. Lin, S.X., Chen, J., Mazumdar, M., Poirier, D., Wang, C., Azzi, A. and Zhou, M. (2010) Molecular therapy of breast cancer: progress and future directions. Nat Rev. Endocrinol. 6, 485-493 CrossRef PubMed
4. Park, S.Y, Lee, H.E., Li, H., Shipitsin, M., Gelman, R. and Polyak, K. (2010) Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin. Cancer Res. 16, 876-887 CrossRef PubMed
5. Elzarrad, M.K., Haroon, A., Willecke, K., Dobrowolski, R., Gillespie, M.N. and Al-Mehdi, A.B. (2008) Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med. 6, 20 CrossRef PubMed
6. Kanczuga-Koda, L., Sulkowski, S., Lenczewski, A., Koda, M., Wincewicz, A., Baltaziak, M. and Sulkowska, M. (2006) Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J. Clin. Pathol. 59, 429-433 CrossRef PubMed
7. Conklin, C.M., Bechberger, J.F., MacFabe, D., Guthrie, N., Kurowska, E.M. and Naus, C.C. (2007) Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells. Carcinogenesis 28, 93-100 CrossRef PubMed
8. Cotrina, M.L., Lin, J.H. and Nedergaard, M. (2008) Adhesive properties of connexin hemichannels. Glia 56, 1791-1798 CrossRef PubMed
9. Xu, X., Francis, R., Wei, C.J., Linask, K.L. and Lo, C.W. (2006) Connexin 43-mediated modulation of polarized cell movement and the directional migration of cardiac neural crest cells. Development 133, 3629-3639 CrossRef PubMed
10. Homkajorn, B., Sims, N.R. and Muyderman, H. (2010) Connexin 43 regulates astrocytic migration and proliferation in response to injury. Neurosci. Lett 486, 197-201 CrossRef PubMed
11. Behrens, J., Kameritsch, P., Wallner, S., Pohl, U. and Pogoda, K. (2010) The carboxyl tail of Cx43 augments p38 mediated cell migration in a gap junction-independent manner. Eur. J. Cell Biol. 89, 828-838 CrossRef PubMed
12. Petri, A., Lindow, M. and Kauppinen, S. (2009) MicroRNA silencing in primates: towards development of novel therapeutics. Cancer Res. 69, 393-395 CrossRef PubMed
13. Zhang, H., Li, Y. and Lai, M. (2010) The microRNA network and tumor metastasis. Oncogene 29, 937-948 CrossRef PubMed
14. Nana-Sinkam, S.P. and Croce, C.M. (2013) Clinical applications for microRNAs in cancer. Clin. Pharmacol. Ther. 93, 98-104 CrossRef PubMed
15. Jovanovic, M. and Hengartner, M.O. (2006) miRNAs and apoptosis: RNAs to die for. Oncogene 25, 6176-6187 CrossRef PubMed
16. Knezevic, J., Pfefferle, A.D., Petrovic, I., Greene, S.B., Perou, C.M. and Rosen, J.M. (2015) Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene CrossRef
17. Lin, Y., Liu, A.Y., Fan, C., Zheng, H., Li, Y., Zhang, C., Wu, S., Yu, D., Huang, Z., Liu, F. et al. (2015) MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci. Rep. 5, 9995 CrossRef PubMed
18. Benaich, N., Woodhouse, S., Goldie, S.J., Mishra, A., Quist, S.R. and Watt, F.M. (2014) Rewiring of an epithelial differentiation factor, miR-203, to inhibit human squamous cell carcinoma metastasis. Cell Rep. 9, 104-117 CrossRef PubMed
19. Cheng, J., Guo, S., Chen, S., Mastriano, S.J., Liu, C., D'Alessio, A.C., Hysolli, E., Guo, Y., Yao, H., Megyola, C.M. et al. (2013) An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. Cell Rep. 5, 471-481 CrossRef PubMed
20. Han, C., Liu, Y., Wan, G., Choi, H.J., Zhao, L., Ivan, C., He, X., Sood, A.K., Zhang, X. and Lu, X. (2014) The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression. Cell Rep. 8, 1447-1460 CrossRef PubMed
21. Zhao, H., Chen, D., Wang, J., Yin, Y., Gao, Q. and Zhang, Y. (2014) Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast. Int. J. Clin. Exp. Pathol. 7, 670-676 PubMed
22. Miao, H., Zhang, Y., Lu, Z., Yu, L. and Gan, L. (2012) FOXO1 increases CCL20 to promote NF-kappaB-dependent lymphocyte chemotaxis. Mol. Endocrinol. 26, 423-437 CrossRef PubMed
23. Anderson, C., Catoe, H. and Werner, R. (2006) MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res. 34, 5863-5871 CrossRef PubMed
24. Li, Z., Zhou, Z. and Donahue, H.J. (2008) Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential. Clin. Exp. Metastasis 25, 265-272 CrossRef PubMed
25. Fu, Y., Jiang, B.Q., Wu, Y., Li, Z.D. and Zhuang, Z.G. (2013) Hsa-miR-206 inhibits the migration and invasion of breast cancer by targeting Cx43. Zhonghua Yi Xue Za Zhi 93, 2890-2894 PubMed
26. Grek, C.L., Rhett, J.M., Bruce, J.S., Abt, M.A., Ghatnekar, G.S. and Yeh, E.S. (2015) Targeting connexin 43 with alpha-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1. BMC Cancer 15, 296 CrossRef PubMed
27. Zhang, A., Hitomi, M., Bar-Shain, N., Dalimov, Z., Ellis, L., Velpula, K.K., Fraizer, G.C., Gourdie, R.G. and Lathia, J.D. (2015) Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migration. Oncotarget 6, 11640-11651 PubMed
28. Zhao, J.Q., Sun, F.J., Liu, S.S., Yang, J., Wu, Y.Q., Li, G.S., Chen, Q.Y. and Wang, J.X. (2013) Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients. Asian Pac. J. Cancer Prev. 14, 639-643 CrossRef PubMed